These results, together with the in vitro and in vivo tumor growth inhibition results, suggested that overexpression of HIPK2 and the use of chemotherapeutic drugs could both increase the expression of proapoptotic genes, thereby suppressing tumor cell growth. The gene discussed is HIPK2; the disease is neoplasm.